Skip to main content

4 Result(s)

within Article Remove this filter Wansik Yu Remove this filter Pharmacology/Toxicology Remove this filter

and

  1. No Access

    Article

    Phosphorylated AMP-activated protein kinase expression associated with prognosis for patients with gastric cancer treated with cisplatin-based adjuvant chemotherapy

    The present study analyzed the expression of phosphorylated AMP-activated protein kinase (pAMPK), Fyn kinase, and pyruvate dehydrogenase kinase-1 (PDK-1) and their impact on the survival of patients with resec...

    Byung Woog Kang, Ji Yun Jeong, Yee Soo Chae… in Cancer Chemotherapy and Pharmacology (2012)

  2. No Access

    Article

    Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer

    Purpose The feasibility of a 3-week combination of S-1 and cisplatin as an adjuvant chemotherapy for patients with curatively resected gastric cancer was investigated. Experimental design

    Byung Woog Kang, Jong Gwang Kim, Yee Soo Chae, Yoo ** Lee… in Investigational New Drugs (2012)

  3. No Access

    Article

    TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin

    The present study analyzed the polymorphisms of apoptosis-related genes and their impact on the response to chemotherapy and survival of patients with advanced gastric cancer.

    Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae… in Cancer Chemotherapy and Pharmacology (2009)

  4. No Access

    Article

    Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer

    Since a weekly administration of paclitaxel has demonstrated a sustained efficacy and more favorable toxicity profile than a 3-weekly administration for various solid tumors, the present study was conducted to...

    Jong Gwang Kim, Sang Kyun Sohn, Hong Suk Song… in Cancer Chemotherapy and Pharmacology (2007)